位置:首页 > 蛋白库 > PBPA_CLOPE
PBPA_CLOPE
ID   PBPA_CLOPE              Reviewed;         679 AA.
AC   Q8XJ01;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   03-AUG-2022, entry version 119.
DE   RecName: Full=Penicillin-binding protein 1A;
DE            Short=PBP1;
DE   Includes:
DE     RecName: Full=Penicillin-insensitive transglycosylase;
DE              EC=2.4.1.129 {ECO:0000250|UniProtKB:P02918};
DE     AltName: Full=Peptidoglycan TGase;
DE   Includes:
DE     RecName: Full=Penicillin-sensitive transpeptidase;
DE              EC=3.4.16.4 {ECO:0000250|UniProtKB:P02918};
DE     AltName: Full=DD-transpeptidase;
GN   Name=pbpA; OrderedLocusNames=CPE1962;
OS   Clostridium perfringens (strain 13 / Type A).
OC   Bacteria; Firmicutes; Clostridia; Eubacteriales; Clostridiaceae;
OC   Clostridium.
OX   NCBI_TaxID=195102;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=13 / Type A;
RX   PubMed=11792842; DOI=10.1073/pnas.022493799;
RA   Shimizu T., Ohtani K., Hirakawa H., Ohshima K., Yamashita A., Shiba T.,
RA   Ogasawara N., Hattori M., Kuhara S., Hayashi H.;
RT   "Complete genome sequence of Clostridium perfringens, an anaerobic flesh-
RT   eater.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:996-1001(2002).
CC   -!- FUNCTION: Cell wall formation. Synthesis of cross-linked peptidoglycan
CC       from the lipid intermediates. The enzyme has a penicillin-insensitive
CC       transglycosylase N-terminal domain (formation of linear glycan strands)
CC       and a penicillin-sensitive transpeptidase C-terminal domain (cross-
CC       linking of the peptide subunits). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-
CC         Ala)](n)-di-trans,octa-cis-undecaprenyl diphosphate + beta-D-GlcNAc-
CC         (1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-
CC         cis-undecaprenyl diphosphate = [GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-
CC         D-Glu-L-Lys-D-Ala-D-Ala)](n+1)-di-trans-octa-cis-undecaprenyl
CC         diphosphate + di-trans,octa-cis-undecaprenyl diphosphate + H(+);
CC         Xref=Rhea:RHEA:23708, Rhea:RHEA-COMP:9602, Rhea:RHEA-COMP:9603,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:58405, ChEBI:CHEBI:60033,
CC         ChEBI:CHEBI:78435; EC=2.4.1.129;
CC         Evidence={ECO:0000250|UniProtKB:P02918};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Preferential cleavage: (Ac)2-L-Lys-D-Ala-|-D-Ala. Also
CC         transpeptidation of peptidyl-alanyl moieties that are N-acyl
CC         substituents of D-alanine.; EC=3.4.16.4;
CC         Evidence={ECO:0000250|UniProtKB:P02918};
CC   -!- PATHWAY: Cell wall biogenesis; peptidoglycan biosynthesis.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass type II
CC       membrane protein {ECO:0000305}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the
CC       glycosyltransferase 51 family. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the transpeptidase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BA000016; BAB81668.1; -; Genomic_DNA.
DR   AlphaFoldDB; Q8XJ01; -.
DR   SMR; Q8XJ01; -.
DR   STRING; 195102.gene:10491231; -.
DR   DrugBank; DB01061; Azlocillin.
DR   DrugBank; DB00833; Cefaclor.
DR   DrugBank; DB00456; Cefalotin.
DR   DrugBank; DB01139; Cefapirin.
DR   DrugBank; DB01066; Cefditoren.
DR   DrugBank; DB00267; Cefmenoxime.
DR   DrugBank; DB00229; Cefotiam.
DR   DrugBank; DB01112; Cefuroxime.
DR   DrugBank; DB04133; Degraded Cephaloridine.
DR   DrugBank; DB00301; Flucloxacillin.
DR   DrugBank; DB00447; Loracarbef.
DR   DrugBank; DB00948; Mezlocillin.
DR   DrugBank; DB00713; Oxacillin.
DR   DrugBank; DB00417; Phenoxymethylpenicillin.
DR   DrugBank; DB01604; Pivampicillin.
DR   DrugBank; DB01605; Pivmecillinam.
DR   DrugCentral; Q8XJ01; -.
DR   CAZy; GT51; Glycosyltransferase Family 51.
DR   EnsemblBacteria; BAB81668; BAB81668; BAB81668.
DR   KEGG; cpe:CPE1962; -.
DR   HOGENOM; CLU_006354_2_2_9; -.
DR   OMA; AVQMPYI; -.
DR   UniPathway; UPA00219; -.
DR   Proteomes; UP000000818; Chromosome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008658; F:penicillin binding; IEA:InterPro.
DR   GO; GO:0008955; F:peptidoglycan glycosyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0009002; F:serine-type D-Ala-D-Ala carboxypeptidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0071555; P:cell wall organization; IEA:UniProtKB-KW.
DR   GO; GO:0009252; P:peptidoglycan biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW.
DR   GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.3810.10; -; 1.
DR   Gene3D; 3.40.710.10; -; 1.
DR   InterPro; IPR012338; Beta-lactam/transpept-like.
DR   InterPro; IPR001264; Glyco_trans_51.
DR   InterPro; IPR023346; Lysozyme-like_dom_sf.
DR   InterPro; IPR036950; PBP_transglycosylase.
DR   InterPro; IPR001460; PCN-bd_Tpept.
DR   Pfam; PF00912; Transgly; 1.
DR   Pfam; PF00905; Transpeptidase; 1.
DR   SUPFAM; SSF53955; SSF53955; 1.
DR   SUPFAM; SSF56601; SSF56601; 1.
PE   3: Inferred from homology;
KW   Antibiotic resistance; Carboxypeptidase; Cell membrane; Cell shape;
KW   Cell wall biogenesis/degradation; Glycosyltransferase; Hydrolase; Membrane;
KW   Multifunctional enzyme; Peptidoglycan synthesis; Protease;
KW   Reference proteome; Signal-anchor; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..679
FT                   /note="Penicillin-binding protein 1A"
FT                   /id="PRO_0000321877"
FT   TOPO_DOM        1..30
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        31..51
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        52..679
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   REGION          1..20
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          72..244
FT                   /note="Transglycosylase"
FT                   /evidence="ECO:0000250"
FT   REGION          378..663
FT                   /note="Transpeptidase"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        1..17
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        111
FT                   /note="Proton donor; for transglycosylase activity"
FT                   /evidence="ECO:0000250|UniProtKB:P02919"
FT   ACT_SITE        417
FT                   /note="Acyl-ester intermediate; for transpeptidase
FT                   activity"
FT                   /evidence="ECO:0000250|UniProtKB:P02919"
SQ   SEQUENCE   679 AA;  75177 MW;  FCEE7683E6C07A3B CRC64;
     MTERKREHKD RKQNKNSPKN QSKVTKFLKW FFIGILLLGI TAVTVVGIYV LSIIRSSPEL
     DVQAIQSLNQ PSILYDDQGN FMDNVITREQ RYVVKSEEIP DNLKKAFVAI EDERFYEHKG
     IDIKRIFGVI ASNIKGKLSG SNTVQGASTI TQQLIKNAVL TNEVSYERKI KEMYLALELE
     KHLSKDEILT TYLNTIPMGG YQYGVSAAAQ RFFSKNVSDL NLVECAYLGG LTQAPTSYDG
     LSEANKENPS RYLNRTKSVL FKMHELGYIS SEQYNDAINE IDTNGIKFTP NNKLSKTNFE
     WFTRPAITQV KQDLMDKYKY TQEEVDKLIA NGGLKIYTSM DRNLQNNVQK VLDDPNNYKA
     ITNNPNEKNE DGVYKLQASA TIIDYKTGHV KALVGGRGEQ PAMSHNRAYY DLKSIGSATK
     PLTVYGPAID LGLGGAGSVV NDSPLSNKEL SSTGYKDQPK NEYNSYRGPL TFREAIKISS
     NLAAIKVANE VGVSNSIAYG EKLGLVYGPH SRGISTTALG QFQNDPNNPD GGNTYTLASA
     FGVFGNNGVK TNAKLYTKVL DSHGNVILDT STPEETKIFS PQASYIVYDM LKDQVESGSA
     KSAKFGNIPV AGKTGTTTGD KDYLFAGLTP YYSAAIWIGY DKPREMRTSS GTVTSPIFGK
     IMGLAHKDLQ YKEVDNLVE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024